ReviewMetabolism: clinical and experimental2020

Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease.

Michelle T Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.